Consort Medical PLC Notice of Results (7108V)
November 07 2017 - 1:00AM
UK Regulatory
TIDMCSRT
RNS Number : 7108V
Consort Medical PLC
07 November 2017
Consort Medical plc
7 November 2017
Notice of Results
Consort Medical plc ("Consort Medical", "Consort") (LSE: CSRT),
a leading, global, single source pharma services drug and delivery
device company, will announce its interim results for the six
months ended 31 October 2017 on Tuesday, 5 December 2017.
ENDS
Enquiries:
Consort Medical Tel: +44 1442 867 920
Jonathan Glenn - Chief Executive Officer
Paul Hayes - Chief Financial Officer
FTI Consulting Tel: +44 20 3727 1000
Ben Atwell / Simon Conway
Consort Medical plc is a leading, global, single source drug and
delivery device company (CDMO). We are at the leading edge of
innovation and we are committed to investing in patient, clinician
and customer driven innovation to create new treatments, new
markets and new opportunities.
Our businesses
Bespak is a global market leader in the manufacture of drug
delivery devices for pharmaceutical partner companies, including
respiratory, nasal, and injectable products, and the manufacture of
devices for the point of care diagnostics market.
www.bespak.com.
Aesica is a leading provider of finished dose and active
pharmaceutical ingredient (API) development and manufacturing
services to pharmaceutical partners. www.aesica-pharma.com.
We employ c.2,000 people globally of which c.1,400 are located
in the UK. We have UK facilities in King's Lynn, Cambridge, Nelson,
Milton Keynes, Cramlington, Queenborough and Hemel Hempstead,
German facilities in Monheim and Zwickau and a facility in
Pianezza, Italy. Consort Medical is a public company quoted on the
premium list of the London Stock Exchange (LSE: CSRT).
www.consortmedical.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NORBRBDBBGGBGRL
(END) Dow Jones Newswires
November 07, 2017 02:00 ET (07:00 GMT)
Consort Medical (LSE:CSRT)
Historical Stock Chart
From Apr 2024 to May 2024
Consort Medical (LSE:CSRT)
Historical Stock Chart
From May 2023 to May 2024